2.1
Atogepant (Aquipta, AbbVie) is indicated for 'prophylaxis of migraine in adults who have at least 4 migraine days per month'.
2 Information about atogepant
Marketing authorisation indication
Dosage in the marketing authorisation
2.2
The dosage schedule is available in the summary of product characteristics for atogepant.
Price
2.3
The list price of atogepant is £182.16 for 28 tablets (excluding VAT; company information).
2.4
Costs may vary in different settings because of negotiated procurement discounts.